Jin H. Heo
Songnam, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
Journal: Yonsei medical journal
Published: January 19, 2021
Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy.
Journal: American journal of physiology. Renal physiology
Published: August 08, 2019
A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer.
Journal: Gynecologic oncology
Published: October 05, 2018
A clinicopathologic review and obstetric outcome of uterine smooth muscle tumor of uncertain malignant potential (STUMP) in a single institution.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: March 26, 2018
Fascin expression is inversely correlated with breast cancer metastasis suppressor 1 and predicts a worse survival outcome in node-negative breast cancer patients.
Journal: Journal of Cancer
Published: July 23, 2017
miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3.
Journal: Oncotarget
Published: March 26, 2017
Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.
Journal: Journal of clinical pathology
Published: May 11, 2015
Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.
Journal: International journal of oncology
Published: November 07, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026